Achieve Life Sciences, Inc. cash flow statement

In fiscal 2019, Achieve Life Sciences, Inc.'s operations generated −$15.2m of cash; it spent $53,000 on capital projects, leaving free cash flow of −$15.3m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Achieve Life Sciences, Inc.: cash flow statement, annual
Fiscal year	2018Dec 2018	2019Dec 2019
Cash from operations	−11	−15
Depreciation and amortisation	0	0
Stock-based pay	1	1
Capital spending	0	0
Free cash flow	−11	−15
Free cash flow after stock pay	−12	−16
Shares issued	1	—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Achieve Life Sciences, Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Achieve Life Sciences, Inc.